Kate Markey

Kate Markey is an Assistant Professor at the Translational Science and Therapeutics Division of Fred Hutch Cancer Center and the Division of Hematology and Oncology at the University of Washington School of Medicine. She is a physician-scientist specializing in hematopoietic stem cell transplantation and cellular therapy.

Her educational background includes:

• M.B.B.S. from The University of Queensland, Australia
• Ph.D. in Immunology from The University of Queensland, Australia
• Master of Clinical Research Methods from Monash University, Australia
• Bachelor of Engineering (Chemical) from The University of Queensland, Australia

Dr. Markey's research focuses on the intersection of the gut microbiome, the immune system, and cancer treatment outcomes, particularly in bone marrow transplantation and cellular immunotherapies. Her lab investigates how intestinal microbiome disruptions influence graft-versus-host disease (GVHD) development and immune recovery, aiming to develop microbiome-targeted interventions for improved transplant outcomes. She emphasizes clinical-translational synergy, using patient observations to drive laboratory investigations.

Her scientific recognition includes:

• Fellow of the Royal Australasian College of Physicians (FRACP)

Details regarding specific research grants and student advising were not provided in the source materials, though her laboratory actively trains researchers in microbiome-immunology interfaces. Dr. Markey leads a dedicated research team at Fred Hutch Cancer Center focused on microbial determinants of cancer treatment success, with work featured in major scientific communications including studies on pre-transplant microbiome impacts on GVHD risk.